2.19
price up icon1.86%   0.04
after-market Dopo l'orario di chiusura: 2.19
loading

Alx Oncology Holdings Inc Azioni (ALXO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
2.17%
23.02
22.53 26.65 31.82 30.61
Interest Income/Expense
6.13%
0.383
0.408 0.405 0.406 0.427
Depreciation and Amortization
50.00%
0.10
0.20 0.20 0.20 0.20
Operating Income/Loss
2.17%
-23.02
-22.53 -26.65 -31.82 -30.61
Income/Loss From Continuing Operations Before Tax
3.18%
-22.85
-22.14 -25.95 -30.75 -29.16
Income/Loss From Continuing Operations After Tax
3.18%
-22.85
-22.14 -25.95 -30.75 -29.16
Net Income/Loss
3.18%
-22.85
-22.14 -25.95 -30.75 -29.16
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.62%
0.2061
53.58 53.45 53.36 0.6304
Diluted Average Shares
99.62%
0.2061
53.58 53.45 53.36 0.6304
Basic Earnings Per Share
2.44%
-0.42
-0.41 -0.49 -0.58 -0.53
Diluted Earnings Per Share
2.44%
-0.42
-0.41 -0.49 -0.58 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
Capitalizzazione:     |  Volume (24 ore):